Buscar resultados de ensayos clínicos
Anaplastic Large Cell Lymphoma - 340 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma Condición: Large Cell Lymphoma Fecha: 2004-12-10 Intervenciones: Drug: SGN-30 |
Recruiting |
Nombre del estudio: Pilot Study of Crizotinib in Relapsed ALK+ Lymphomas Condición: Anaplastic Large Cell Lymphoma, ALK-Positive Fecha: 2015-04-03 Intervenciones: Drug: crizotinib |
Withdrawn |
Nombre del estudio: MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma Condición: Lymphoma, Large-Cell Fecha: 2006-03-01 Intervenciones: Drug: MDX-060 |
Active, not recruiting |
Nombre del estudio: Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma Condición:
|
Completed |
Nombre del estudio: A Phase 2 Open Label Trial of Brentuximab Vedotin (SGN-35) for Systemic Anaplastic Large Cell Lymphoma Condición:
Fecha: 2009-03-19 Intervenciones: Drug: brentuximab vedotin 1.8 mg/kg every 3 weeks by IV infusion |
Recruiting |
Nombre del estudio: Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK + Condición: ALCL Fecha: 2016-09-07 Intervenciones: Other: Blood sample |
Recruiting |
Nombre del estudio: Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL) Condición:
Fecha: 2016-10-18 Intervenciones: Drug: Brentuximab Vedotin Brentuximab vedotin IV infusion. |
Completed |
Nombre del estudio: Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's Lymphoma Condición: Lymphoma Fecha: 1999-11-01 Intervenciones: Biological: monoclonal antibody HeFi-1 |
Recruiting |
Nombre del estudio: AT13387 in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Diffuse Large B-cell Lymphoma Condición:
|
Withdrawn |
Nombre del estudio: Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma Condición:
|